{{Rsnum
|rsid=17382202
|Gene=PDE4D
|Chromosome=5
|position=59684120
|Orientation=plus
|GMAF=0.1492
|Gene_s=PDE4D
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 60.2 | 37.2 | 2.7
| HCB | 67.2 | 32.1 | 0.7
| JPT | 85.8 | 13.3 | 0.9
| YRI | 98.6 | 1.4 | 0.0
| ASW | 93.0 | 7.0 | 0.0
| CHB | 67.2 | 32.1 | 0.7
| CHD | 78.9 | 17.4 | 3.7
| GIH | 49.5 | 44.6 | 5.9
| LWK | 98.2 | 1.8 | 0.0
| MEX | 58.6 | 41.4 | 0.0
| MKK | 98.1 | 1.9 | 0.0
| TSI | 65.7 | 30.4 | 3.9
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23241943
  |Trait=Response to antipsychotic treatment
  |Title=Genome-wide association study of patient-rated and clinician-rated global impression of severity during antipsychotic treatment.
  |RiskAllele=T
  |Pval=4E-8
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}